In two recent cases, the Federal Circuits held that claim amendments at issue were “tangential” to the “equivalent” at issue, and upheld findings of infringement. The case details are below:  Case #1: Ajinomoto Co. v. ITC  The claim amendment at issue related to an encoding nucleotide sequence. The original claim language recited “a protein which […]

{1:50 minutes to read} In a recent case, Life Technologies Corp. v. Promega Corp., the Supreme Court reinterpreted the meaning of the patent infringement statute 35 U.S.C. § 271(f)(1). The statute reads: “Whoever without authority supplies or causes to be supplied in or from the United States all or a substantial portion of the components […]